LBP AM’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$84.9M Sell
73,384
-91,514
-55% -$108M 0.76% 19
2026
Q2
$198M Sell
164,898
-22,101
-12% -$22.6M 1.98% 10
2026
Q1
$172M Sell
186,999
-37,167
-17% -$37.7M 2.35% 7
2025
Q4
$241M Buy
224,166
+9,107
+4% +$8.71M 2.79% 6
2025
Q3
$164M Buy
215,059
+21,875
+11% +$16.3M 2.02% 8
2025
Q2
$151M Buy
193,184
+81,928
+74% +$63.7M 2.12% 9
2025
Q1
$91.9M Sell
111,256
-22,723
-17% -$18.9M 1.42% 13
2024
Q4
$103M Buy
133,979
+30,555
+30% +$25.3M 1.4% 13
2024
Q3
$91.6M Buy
103,424
+60,876
+143% +$54.7M 1.38% 13
2024
Q2
$38.5M Buy
42,548
+264
+0.6% +$211K 1.58% 9
2024
Q1
$32.9M Sell
42,284
-6,631
-14% -$4.72M 1.31% 12
2023
Q4
$28.5M Sell
48,915
-9,213
-16% -$5.38M 0.63% 39
2023
Q3
$31.2M Buy
58,128
+7,959
+16% +$4.1M 0.69% 38
2023
Q2
$23.5M Buy
50,169
+9,990
+25% +$4.19M 0.56% 54
2023
Q1
$13.8M Sell
40,179
-2,210
-5% -$745K 0.35% 77
2022
Q4
$15.5M Buy
+42,389
New +$15M 0.44% 61

Other funds holding LLY

LBP AM's LLY Position: Q3 2026 in Review

LBP AM reduced its Eli Lilly (LLY) stake by 55% in Q3 2026, selling an estimated $108M and leaving 73,384 shares worth $84.9M. The position accounts for 0.76% of the portfolio, ranked #19.

LBP AM first reported a position in LLY in Q4 2022 and has held it in 16 quarters since. The position peaked at $241M in Q4 2025. 2,846 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • LBP AM held 73,384 shares of Eli Lilly worth $84.9M as of Q3 2026.
  • LBP AM sold 91,514 Eli Lilly shares in Q3 2026, an estimated $108M.
  • Eli Lilly made up 0.76% of LBP AM's portfolio in Q3 2026, its #19 holding.
  • LBP AM first reported a position in Eli Lilly in Q4 2022 and has held it in 16 quarters since.
  • LBP AM's Eli Lilly position peaked at $241M in Q4 2025.
  • 2,846 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on LBP AM's 13F filing for Q3 2026, filed 6 Nov 2026.